Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,018 public trials 2,029 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Trial of Obinutuzumab,GDC-0199 Plus Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma Patients

NCT02558816

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: CHU Angers Angers, France

CHU de Dijon Dijon, France

Hôpital Claude Huriez - CHRU de Lille Lille, France

Hôpital Saint Eloi Montpellier, France

View Trial Details

Completed

Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis

NCT01864018

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +17 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Cyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma Cells

NCT04813653

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Tel Aviv Sourasky Medical Center Tel Aviv, Israel

View Trial Details

Completed

Living Conditions After Non-Hodgkin's Lymphoma in France

NCT05583318

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Chu Dijon Bourgogne Dijon, France

View Trial Details

Completed

Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma

NCT00878254

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: University of Miami Miami, Florida, United States

View Trial Details

Completed

Multiple Myeloma Yoga Pilot Study

NCT06061302

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Arizona Cancer Center Tucson, Arizona, United States

View Trial Details

Completed

A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma

NCT05011097

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin, Tianjin Municipality, China

The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Completed

Haplo Peripheral Blood Sct In GVHD Prevention

NCT04473911

Conditions: ALL, AML, Acute Lymphoblastic Leukemia, +37 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma

NCT02956382

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Georgetown Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States

John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States

Seattle Cancer Care Alliance Seattle, Washington, United States

View Trial Details

Completed

A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas

NCT01051635

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions